Rexlemestrocel-L
Sponsors
Mesoblast, Inc., Mesoblast, Ltd.
Conditions
Chronic Heart FailureDegenerative Disc Disease
Phase 3
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure
CompletedNCT02032004
Start: 2014-03-03End: 2020-01-30Updated: 2026-03-23
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain
CompletedNCT02412735
Start: 2015-03-06End: 2021-06-15Updated: 2022-10-19